Overview

Tetrabenazine for Partial Responders

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
Purpose of Study: A) To improve outcome in large population of antipsychotic patients with schizophrenia or schizoaffective who are only partial responders B) To increase understanding of pharmacology and mechanisms of action underlying antipsychotic effect Hypothesis/Objectives of the Study: Tetrabenazine, through its pre-synaptic action, should augment the post-synaptic effects of an antipsychotic. Background and Rationale for the study: Preliminary evidence that other amine-depleting agents e.g., reserpine, can induce such an effect
Phase:
N/A
Details
Lead Sponsor:
Centre for Addiction and Mental Health
Collaborator:
Stanley Medical Research Institute
Treatments:
Antipsychotic Agents
Tetrabenazine